CRA International [CRAI] vs Equifax [EFX] Detailed Stock Comparison
CRA International
NASDAQ
Loading...
Equifax
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: CRA International wins in 12 metrics, Equifax wins in 8 metrics, with 0 ties. CRA International appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CRA International | Equifax | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 22.57 | 46.75 | CRA International |
| Price-to-Book Ratio | 6.21 | 5.82 | Equifax |
| Debt-to-Equity Ratio | 113.65 | 93.55 | Equifax |
| PEG Ratio | 24.24 | 25.48 | CRA International |
| EV/EBITDA | 14.62 | 18.98 | CRA International |
| Profit Margin (TTM) | 7.93% | 10.95% | Equifax |
| Operating Margin (TTM) | 10.56% | 20.22% | Equifax |
| EBITDA Margin (TTM) | 10.56% | 20.22% | Equifax |
| Return on Equity | 29.09% | 12.76% | CRA International |
| Return on Assets (TTM) | 9.21% | 5.80% | CRA International |
| Free Cash Flow (TTM) | $33.11M | $813.00M | Equifax |
| Dividend Yield | 1.26% | 0.46% | CRA International |
| 1-Year Return | 21.25% | -13.87% | CRA International |
| Price-to-Sales Ratio (TTM) | 1.72 | 5.06 | CRA International |
| Enterprise Value | $1.43B | $34.53B | Equifax |
| EV/Revenue Ratio | 2.01 | 5.91 | CRA International |
| Gross Profit Margin (TTM) | 31.22% | 56.76% | Equifax |
| Revenue per Share (TTM) | $106 | $47 | CRA International |
| Earnings per Share (Diluted) | $8.26 | $5.13 | CRA International |
| Beta (Stock Volatility) | 0.90 | 1.64 | CRA International |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
CRA International vs Equifax Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CRA International | -0.39% | 9.56% | -4.46% | 0.54% | -2.22% | 1.78% |
| Equifax | -0.87% | -0.08% | -9.22% | -11.56% | -5.18% | -4.51% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CRA International | 21.25% | 94.37% | 302.90% | 708.06% | 1,010.97% | 279.83% |
| Equifax | -13.87% | 7.86% | 45.57% | 129.53% | 694.07% | 603.46% |
Performance & Financial Health Analysis: CRA International vs Equifax
| Metric | CRAI | EFX |
|---|---|---|
| Market Information | ||
| Market Cap | $1.23B | $29.54B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 90,770 | 1,042,150 |
| 90 Day Avg. Volume | 117,560 | 1,099,837 |
| Last Close | $186.42 | $239.81 |
| 52 Week Range | $152.57 - $214.01 | $199.98 - $309.63 |
| % from 52W High | -12.89% | -22.55% |
| All-Time High | $214.01 (Feb 17, 2025) | $309.63 (Sep 16, 2024) |
| % from All-Time High | -12.89% | -22.55% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.07% |
| Quarterly Earnings Growth | 0.85% | 0.17% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.11% |
| Operating Margin (TTM) | 0.11% | 0.20% |
| Return on Equity (TTM) | 0.29% | 0.13% |
| Debt to Equity (MRQ) | 113.65 | 93.55 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $30.02 | $41.22 |
| Cash per Share (MRQ) | $2.95 | $1.53 |
| Operating Cash Flow (TTM) | $36.87M | $1.39B |
| Levered Free Cash Flow (TTM) | $70.87M | $864.12M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.26% | 0.46% |
| Last 12-Month Dividend | $2.38 | $1.17 |
Valuation & Enterprise Metrics Analysis: CRA International vs Equifax
| Metric | CRAI | EFX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 22.57 | 46.75 |
| Forward P/E | 24.24 | 25.48 |
| PEG Ratio | 24.24 | 25.48 |
| Price to Sales (TTM) | 1.72 | 5.06 |
| Price to Book (MRQ) | 6.21 | 5.82 |
| Market Capitalization | ||
| Market Capitalization | $1.23B | $29.54B |
| Enterprise Value | $1.43B | $34.53B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.01 | 5.91 |
| Enterprise to EBITDA | 14.62 | 18.98 |
| Risk & Other Metrics | ||
| Beta | 0.90 | 1.64 |
| Book Value per Share (MRQ) | $30.02 | $41.22 |
Financial Statements Comparison: CRA International vs Equifax
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CRAI | EFX |
|---|---|---|
| Revenue/Sales | $181.85M | $1.44B |
| Cost of Goods Sold | $120.35M | $656.70M |
| Gross Profit | $61.50M | $785.30M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $25.55M | $235.80M |
| EBITDA | $32.81M | $414.70M |
| Pre-Tax Income | $24.65M | $185.40M |
| Income Tax | $6.64M | $51.60M |
| Net Income (Profit) | $18.00M | $133.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CRAI | EFX |
|---|---|---|
| Cash & Equivalents | $25.60M | $195.20M |
| Total Current Assets | $278.12M | $1.48B |
| Total Current Liabilities | $270.50M | $1.73B |
| Long-Term Debt | $80.95M | $4.32B |
| Total Shareholders Equity | $227.32M | $5.11B |
| Retained Earnings | $240.03M | $6.10B |
| Property, Plant & Equipment | $121.44M | $285.10M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CRAI | EFX |
|---|---|---|
| Operating Cash Flow | $-80.77M | $223.90M |
| Capital Expenditures | $-974,000 | N/A |
| Free Cash Flow | $-80.97M | $116.70M |
| Debt Repayment | $-5.00M | $-48.10M |
| Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CRAI | EFX |
|---|---|---|
| Shares Short | 202,986 | 2.42M |
| Short Ratio | 1.17 | 2.45 |
| Short % of Float | 0.03% | 0.02% |
| Average Daily Volume (10 Day) | 90,770 | 1,042,150 |
| Average Daily Volume (90 Day) | 117,560 | 1,099,837 |
| Shares Outstanding | 6.77M | 123.95M |
| Float Shares | 6.31M | 123.19M |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 0.92% | 1.01% |
Dividend Analysis & Yield Comparison: CRA International vs Equifax
| Metric | CRAI | EFX |
|---|---|---|
| Last 12-Month Dividend | $2.38 | $1.17 |
| Last 12-Month Dividend Yield | 1.26% | 0.46% |
| 3-Year Avg Annual Dividend | $1.80 | $1.30 |
| 3-Year Avg Dividend Yield | 0.30% | 0.17% |
| 3-Year Total Dividends | $5.39 | $3.90 |
| Ex-Dividend Date | Aug 26, 2025 | Feb 21, 2025 |